Lipid-Based Pharmaceutical Nanocarriers for Imaging Applications - Nanotechnology for Biomedical Imaging and Diagnostics - page 76

[103] goto r, Kubo H, okada s. Effect of reticuloendothelial blockade on tissue distribution
of technetium-99-labeled synthetic liposomes in ehrlich solid tumor-bearing mice.
Chem pharm Bull (Tokyo) 1991; 39 :230-232.
[104] ogihara i, Kojima s, Jay m. differential uptake of gallium-67-labeled liposomes
between tumors and inflammatory lesions in rats. J Nucl med 1986; 27 :1300-1307.
[105] soares dC, de oliveira mC, de Barros AL, Cardoso VN, ramaldes gA. Liposomes
radiolabeled with (159)gd: in vitro antitumoral activity, biodistribution study and
scintigraphic image in Ehrlich tumor bearing mice. Eur J pharm sci 2011; 43 :
290-296.
[106] Lin YY, Chang CH, Li JJ, stabin mg, Chang YJ, Chen LC, Lin mH, Tseng YL, Lin WJ,
Lee TW, Ting g, Chang CA, Chen fd, Wang HE. pharmacokinetics and dosimetry of
(111)in/(188)re-labeled pEgylated liposomal drugs in two colon carcinoma-bearing
mouse models. Cancer Biother radiopharm 2011; 26 :373-380.
[107] underwood C, van Eps AW, ross mW, Laverman p, van Bloois L, storm g, schaer Tp.
intravenous technetium-99m labelled pEg-liposomes in horses: a safety and biodistri-
bution study. Equine Vet J 2012; 44 :196-202.
[108] Briele B, Hotze A, oehr p, Biersack HJ, rosanowski f, gorgulla W, Hertberhold C,
Harlapp Jp. Tumour imaging with labelled liposomes. Lancet 1990; 336 :875-876.
[109] simon rH, Ho sY, perkins Cr, d'Arrigo Js. Quantitative assessment of tumor
enhancement by ultrastable lipid-coated microbubbles as a sonographic contrast agent.
invest radiol 1992; 27 :29-34.
[110] osborne mp, richardson VJ, Jeyasingh K, ryman BE. radionuclide-labelled lipo-
somes—a new lymph node imaging agent. int J Nucl med Biol 1979; 6 :75-83.
[111] Erdogan s, medarova Zo, roby A, moore A, Torchilin Vp. Enhanced tumor mr
imaging with gadolinium-loaded polychelating polymer-containing tumor-targeted
liposomes. J magn reson imaging 2008; 27 :574-580.
[112] Liao Z, Wang H, Lv r, Zhao p, sun X, Wang s, su W, Niu r, Chang J. polymeric
liposomes-coated superparamagnetic iron oxide nanoparticles as contrast agent for tar-
geted magnetic resonance imaging of cancer cells. Langmuir 2011; 27 :3100-3105.
[113] mikhaylov g, mikac u, magaeva AA, itin Vi, Naiden Ep, psakhye i, Babes L,
reinheckel T, peters C, Zeiser r, Bogyo m, Turk V, psakhye sg, Turk B, Vasiljeva o.
ferri-liposomes as an mri-visible drug-delivery system for targeting tumours and their
microenvironment. Nat Nanotechnol 2011; 6 :594-602.
[114] Cittadino E, ferraretto m, Torres E, maiocchi A, Crielaard BJ, Lammers T, storm g,
Aime s, Terreno E. mri evaluation of the antitumor activity of paramagnetic liposomes
loaded with prednisolone phosphate. Eur J pharm sci 2012; 45 :436-441.
[115] ding N, Lu Y, Lee rJ, Yang C, Huang L, Liu J, Xiang g. folate receptor-targeted
fluorescent paramagnetic bimodal liposomes for tumor imaging. int J Nanomed
2011; 6 :2513-2520.
[116] Zheng J, Liu J, dunne m, Jaffray dA, Allen C. In vivo performance of a liposomal
vascular contrast agent for CT and mr-based image guidance applications. pharm res
2007; 24 :1193-1201.
[117] Liu g, moake m, Har-El YE, Long Cm, Chan KW, Cardona A, Jamil m, Walczak p,
gilad AA, sgouros g, van Zijl pC, Bulte JW, mcmahon mT. In vivo multicolor molec-
ular mr imaging using diamagnetic chemical exchange saturation transfer liposomes.
magn reson med 2012; 67 :1106-1113.